Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy

Epilepsy & Behavior 2026 Open access

Read full text
Authors: Emanuele Cerulli Irelli, Adolfo Mazzeo, Roberto H. Caraballo, Marco Perulli, Patrick B. Moloney, Javier Peña-Ceballos, Nicola Simeone, Tomasz S. Mieszczanek, Lorenza Marini, Laura Licchetta, Valentina De Giorgis, Gabriela Reyes Valenzuela
+27 more Susanna Casellato, Elisabetta Cesaroni, Francesca F. OPERTO, Jana Domínguez-Carral, Alia Ramírez-Camacho, Alessandro Ferretti, G Santangelo, Angel Aledo-Serrano, Andrea Rüegger, Maria M. Mancardi, Giulia Prato, Antonella Riva, Luca Bergonzini, Duccio Maria Cordelli, Paolo Bonanni, Francesca Bisulli, Giancarlo Di Gennaro, Sara Matricardi, Pasquale Striano, Norman Delanty, Carla Marini, Domenica Battaglia, Carlo Di Bonaventura, Georgia Ramantani, Elena Gardella, Alessandro Orsini, Antonietta Coppola
DOI: 10.1016/j.yebeh.2026.111036
Cited by: 1
References: 33

Fields of Study & Subjects

Cannabis and Cannabinoid Research Epilepsy research and treatment Phosphodiesterase function and regulation

Publication details

Journal / source
Epilepsy & Behavior
Publisher
Elsevier BV
Volume
180
Pages
111036–111036
Publication date
14 April 2026
Language
EN